Evotec Q1 Earnings Call Highlights
Key takeaways
- Why These 3 Large Caps Are Bucking the August Slump
- Group revenue in the first quarter totaled EUR 156.6 million, down 21.7% from the prior-year period, Chief Financial Officer Claire Hinshelwood said.
- → 3 Emerging Markets ETFs to Maximize Exposure to High-Potential Countries
Evotec Q1 Earnings Call Highlights Market Beat Wed, May 6, 2026 at 10:54 PM GMT+7 7 min read EVO Evotec logo Key Points Evotec reported Q1 revenue of EUR 156.6 million (down 21.7% Yo Y) and adjusted EBITDA of negative EUR 21.9 million, with management citing EUR 10.2 million of FX headwinds, the non‑recurrence of a $25 million Sandoz license payment, and softness in discovery demand (revenues would be down ~6% excluding FX and the Sandoz payment).
The company reaffirmed full‑year 2026 guidance of EUR 700–780 million in revenue (or EUR 730–810 million at constant currency) and EUR 0–40 million adjusted EBITDA, saying performance should improve and be weighted to the second half as milestones and D&PD market conditions recover.
Evotec moved its “Horizon” transformation into implementation, booked EUR 75 million of reorganization provisions in Q1, plans to exit the Framingham site, expects personnel adjustments starting Q3 2026, and targets ~EUR 75 million of structural run‑rate savings by end‑2027 (20–30% to materialize in 2026).